Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

[Treated cases of retinopathy of prematurity in Germany : 5-year data from the Retina.net ROP registry].

Walz JM, Bemme S, Reichl S, Akman S, Breuß H, Süsskind D, Glitz B, Müller VC, Wagenfeld L, Gabel-Pfisterer A, Aisenbrey S, Engelmann K, Koutsonas A, Krohne TU, Stahl A; Retina.net ROP-Register-Studiengruppe.

Ophthalmologe. 2018 Jun;115(6):476-488. doi: 10.1007/s00347-018-0701-5. German.

PMID:
29637302
2.

Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity: A Randomized Clinical Trial.

Stahl A, Krohne TU, Eter N, Oberacher-Velten I, Guthoff R, Meltendorf S, Ehrt O, Aisenbrey S, Roider J, Gerding H, Jandeck C, Smith LEH, Walz JM; Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity (CARE-ROP) Study Group.

JAMA Pediatr. 2018 Mar 1;172(3):278-286. doi: 10.1001/jamapediatrics.2017.4838.

3.

Primary vitrectomy for rhegmatogenous retinal detachment in pseudophakic eyes: 20-gauge versus 25-gauge vitrectomy.

Süsskind D, Neuhann I, Hilgers RD, Hagemann U, Szurman P, Bartz-Schmidt KU, Aisenbrey S.

Acta Ophthalmol. 2016 Dec;94(8):824-828. doi: 10.1111/aos.13133. Epub 2016 Jun 8.

4.

The German ROP Registry: data from 90 infants treated for retinopathy of prematurity.

Walz JM, Bemme S, Pielen A, Aisenbrey S, Breuß H, Alex AF, Wagenfeld L, Schiedel S, Krohne TU, Stahl A; Retina.net ROP Registry.

Acta Ophthalmol. 2016 Dec;94(8):e744-e752. doi: 10.1111/aos.13069. Epub 2016 May 20.

5.

Toxic effects of melphalan, topotecan and carboplatin on retinal pigment epithelial cells.

Süsskind D, Hagemann U, Schrader M, Januschowski K, Schnichels S, Aisenbrey S.

Acta Ophthalmol. 2016 Aug;94(5):471-8. doi: 10.1111/aos.12990. Epub 2016 Feb 19.

6.

Investigating short-term toxicity of melphalan in a model of an isolated and superfused bovine retina.

Januschowski K, Krupp C, Mueller S, Hofmann K, Schnichels S, Hagemann U, Spitzer MS, Bartz-Schmidt KU, Aisenbrey S.

Graefes Arch Clin Exp Ophthalmol. 2016 Jan;254(1):91-6. doi: 10.1007/s00417-015-3149-1. Epub 2015 Sep 3.

PMID:
26335534
7.

Proton beam radiotherapy of progressive pediatric choroidal osteoma: first experience.

Süsskind D, Altpeter EK, Moser L, Foerster MH, Aisenbrey S.

Can J Ophthalmol. 2014 Oct;49(5):e123-7. doi: 10.1016/j.jcjo.2014.07.009. No abstract available.

PMID:
25284116
8.

[Rare pigmented fundus tumor].

Süsskind D, Rohrbach JM, Aisenbrey S, Coupland SE, Bartz-Schmidt KU.

Ophthalmologe. 2014 May;111(5):475-8. doi: 10.1007/s00347-013-2973-0. German. No abstract available.

PMID:
24309630
9.

Cataract formation: a possible complication of intra-arterial chemotherapy for retinoblastoma.

Suesskind D, Schrader M, Foerster MH, Ernemann U, Aisenbrey S.

Eur J Ophthalmol. 2014 May-Jun;24(3):449-53. doi: 10.5301/ejo.5000393. Epub 2013 Nov 7.

PMID:
24242220
10.

Pars plana vitrectomy for treatment of advanced Coats' disease--presentation of a modified surgical technique and long-term follow-up.

Suesskind D, Altpeter E, Schrader M, Bartz-Schmidt KU, Aisenbrey S.

Graefes Arch Clin Exp Ophthalmol. 2014 Jun;252(6):873-9. doi: 10.1007/s00417-013-2512-3. Epub 2013 Nov 12.

PMID:
24218042
11.

Electrophysiological toxicity testing of VEGF Trap-Eye in an isolated perfused vertebrate retina organ culture model.

Januschowski K, Schnichels S, Hagemann U, Koch V, Hofmann J, Spitzer MS, Bartz-Schmidt KU, Szurman P, Lüke M, Aisenbrey S.

Acta Ophthalmol. 2014 Jun;92(4):e305-11. doi: 10.1111/aos.12300. Epub 2013 Nov 8.

12.

Comparative toxicity and proliferation testing of aflibercept, bevacizumab and ranibizumab on different ocular cells.

Schnichels S, Hagemann U, Januschowski K, Hofmann J, Bartz-Schmidt KU, Szurman P, Spitzer MS, Aisenbrey S.

Br J Ophthalmol. 2013 Jul;97(7):917-23. doi: 10.1136/bjophthalmol-2013-303130. Epub 2013 May 17.

PMID:
23686000
13.

[Unclear parapapillary tumor in childhood].

Altpeter EK, Süsskind D, Bartz-Schmidt KU, Foerster MH, Aisenbrey S.

Ophthalmologe. 2013 Oct;110(10):986-9. doi: 10.1007/s00347-013-2845-7. German. No abstract available.

PMID:
23681181
14.

[Current therapeutic options in retinopathy of prematurity].

Krohne TU, Aisenbrey S, Holz FG.

Ophthalmologe. 2012 Dec;109(12):1189-97. doi: 10.1007/s00347-012-2618-8. German.

PMID:
23212356
15.

Amniotic bands as a cause of congenital anterior staphyloma.

Schramm C, Rohrbach JM, Reinert S, Mau-Holzmann UA, Aisenbrey S, Bartz-Schmidt KU, Besch D.

Graefes Arch Clin Exp Ophthalmol. 2013 Mar;251(3):959-65. doi: 10.1007/s00417-012-2197-z. Epub 2012 Nov 13.

PMID:
23150045
16.

[Retinopathy of prematurity - pathophysiologic mechanisms and new treatment options].

Stahl A, Aisenbrey S, Krohne TU.

Klin Monbl Augenheilkd. 2012 Oct;229(10):1024-9. doi: 10.1055/s-0032-1315247. Epub 2012 Sep 7. Review. German.

PMID:
22961043
17.

Insight into 8 patients with nonarteritic anterior ischemic optic neuropathy following anti-VEGF injections.

Mansour AM, Schwartz SG, Gregori NZ, Yehoshua Z, Freund KB, Dellatorre K, Aisenbrey S, Hosseini H, Huang JY, Bodla AA, Bhatti MT.

J Neuroophthalmol. 2012 Jun;32(2):193. doi: 10.1097/WNO.0b013e3182569e7b. No abstract available.

PMID:
22549561
18.

Identification of a novel CRYBB2 missense mutation causing congenital autosomal dominant cataract.

Weisschuh N, Aisenbrey S, Wissinger B, Riess A.

Mol Vis. 2012;18:174-80. Epub 2012 Jan 21.

19.

Z-suture: a new knotless technique for transscleral suture fixation of intraocular implants.

Szurman P, Petermeier K, Aisenbrey S, Spitzer MS, Jaissle GB.

Br J Ophthalmol. 2010 Feb;94(2):167-9. doi: 10.1136/bjo.2009.162180.

PMID:
20139289
20.

Non-arteritic anterior ischemic optic neuropathy (NA-AION) after intravitreal injection of bevacizumab (Avastin) for treatment of angoid streaks in pseudoxanthoma elasticum.

Ganssauge M, Wilhelm H, Bartz-Schmidt KU, Aisenbrey S.

Graefes Arch Clin Exp Ophthalmol. 2009 Dec;247(12):1707-10.

PMID:
19916212
21.

Economic penalties and rewards of family formation, gender and education in the low-income sector in Germany.

Aisenbrey S.

Br J Sociol. 2009 Mar;60(1):95-121. doi: 10.1111/j.1468-4446.2008.01220.x.

PMID:
19317679
22.

[Intraocular bevacizumab as palliative therapy in melanoma-metastasis-associated rubeotic secondary glaucoma].

Jaissle GB, Ulmer A, Henke-Fahle S, Aisenbrey S, Fierlbeck G, Bartz-Schmidt KU, Szurman P.

Klin Monbl Augenheilkd. 2009 Jan;226(1):70-2. doi: 10.1055/s-2008-1027782. Epub 2009 Jan 27. German. No abstract available.

PMID:
19173168
23.

Sodium hyaluronate gels as a drug-release system for corticosteroids: release kinetics and antiproliferative potential for glaucoma surgery.

Spitzer MS, Yoeruek E, Kaczmarek RT, Sierra A, Aisenbrey S, Grisanti S, Bartz-Schmidt KU, Szurman P.

Acta Ophthalmol. 2008 Dec;86(8):842-8. doi: 10.1111/j.1755-3768.2007.01149.x.

24.

Analysis of the neuronal marker protein gene product 9.5 in internal limiting membranes after indocyanine-green assisted peeling.

Peters S, Tatar O, Spitzer MS, Szurman P, Aisenbrey S, Lüke M, Adam A, Yoeruek E, Grisanti S.

Retina. 2009 Feb;29(2):243-7. doi: 10.1097/IAE.0b013e3181884fe3.

PMID:
18827736
25.

Bevacizumab as adjuvant for neovascular glaucoma.

Beutel J, Peters S, Lüke M, Aisenbrey S, Szurman P, Spitzer MS, Yoeruek E; Bevacizumab Study Group, Grisanti S.

Acta Ophthalmol. 2010 Feb;88(1):103-9. doi: 10.1111/j.1755-3768.2008.01355.x. Epub 2009 Sep 20.

26.

Vitreous levels of bevacizumab and vascular endothelial growth factor-A in patients with choroidal neovascularization.

Zhu Q, Ziemssen F, Henke-Fahle S, Tatar O, Szurman P, Aisenbrey S, Schneiderhan-Marra N, Xu X; Tübingen Bevacizumab Study Group, Grisanti S.

Ophthalmology. 2008 Oct;115(10):1750-5, 1755.e1. doi: 10.1016/j.ophtha.2008.04.023. Epub 2008 Aug 16.

PMID:
18708261
27.

Efficacy of intravitreal bevacizumab in treating postoperative pseudophakic cystoid macular edema.

Spitzer MS, Ziemssen F, Yoeruek E, Petermeier K, Aisenbrey S, Szurman P.

J Cataract Refract Surg. 2008 Jan;34(1):70-5. doi: 10.1016/j.jcrs.2007.08.021.

PMID:
18165084
28.

Long-term follow-up of macular translocation with 360 degrees retinotomy for exudative age-related macular degeneration.

Aisenbrey S, Bartz-Schmidt KU, Walter P, Hilgers RD, Ayertey H, Szurman P, Thumann G.

Arch Ophthalmol. 2007 Oct;125(10):1367-72. Erratum in: Arch Ophthalmol. 2007 Dec;125(12):1646.

PMID:
17923545
29.

Safety profile of bevacizumab on cultured human corneal cells.

Yoeruek E, Spitzer MS, Tatar O, Aisenbrey S, Bartz-Schmidt KU, Szurman P.

Cornea. 2007 Sep;26(8):977-82.

PMID:
17721300
30.
31.

Primary silicone oil tamponade in the management of severe intraocular foreign body injuries: an 8-year follow-up.

Szurman P, Roters S, Grisanti S, Aisenbrey S, Rohrbach JM, Warga M, Gelisken F, Spitzer MS, Bartz-Schmidt KU.

Retina. 2007 Mar;27(3):304-11.

PMID:
17460585
32.

[Slowly growing lid tumor].

Süsskind D, Aisenbrey S, Metzler G, Rohrbach JM.

Ophthalmologe. 2008 Jan;105(1):74-7. German. No abstract available.

PMID:
17431636
33.

[Changes of the triple flash electroretinogram after 360 degrees retinotomy and macular translocation for subfoveal choroidal neovascularisation in age-related macular degeneration].

Lüke C, Lüke M, Aisenbrey S, Dietlein TS, Bartz-Schmidt KU, Kirchhof B, Walter P.

Klin Monbl Augenheilkd. 2007 Feb;224(2):120-6. German.

PMID:
17309008
34.

Surgical treatment of peripapillary choroidal neovascularisation.

Aisenbrey S, Gelisken F, Szurman P, Bartz-Schmidt KU.

Br J Ophthalmol. 2007 Aug;91(8):1027-30. Epub 2007 Feb 14.

35.

[Bilateral congenital glaucoma in a child with cutis marmorata telangiectatica congenita: a case report].

Spitzer MS, Szurman P, Rohrbach JM, Aisenbrey S.

Klin Monbl Augenheilkd. 2007 Jan;224(1):66-9. German.

PMID:
17260324
36.

Full macular translocation versus photodynamic therapy with verteporfin in the treatment of neovascular age-related macular degeneration: 1-year results of a prospective, controlled, randomised pilot trial (FMT-PDT).

Gelisken F, Voelker M, Schwabe R, Besch D, Aisenbrey S, Szurman P, Grisanti S, Herzau V, Bartz-Schmidt KU.

Graefes Arch Clin Exp Ophthalmol. 2007 Aug;245(8):1085-95.

PMID:
17219106
37.

Intravitreal bevacizumab (Avastin) for occult choroidal neovascularization in age-related macular degeneration.

Aisenbrey S, Ziemssen F, Völker M, Gelisken F, Szurman P, Jaissle G, Grisanti S, Bartz-Schmidt KU.

Graefes Arch Clin Exp Ophthalmol. 2007 Jul;245(7):941-8. Epub 2006 Dec 21.

PMID:
17186262
38.

Retinal pigment epithelial cells synthesize laminins, including laminin 5, and adhere to them through alpha3- and alpha6-containing integrins.

Aisenbrey S, Zhang M, Bacher D, Yee J, Brunken WJ, Hunter DD.

Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5537-44.

39.

Ultrastructural changes after artificial retinal detachment with modified retinal adhesion.

Szurman P, Roters S, Grisanti S, Aisenbrey S, Schraermeyer U, Lüke M, Bartz-Schmidt KU, Thumann G.

Invest Ophthalmol Vis Sci. 2006 Nov;47(11):4983-9.

PMID:
17065517
40.

Differential toxic effect of dissolved triamcinolone and its crystalline deposits on cultured human retinal pigment epithelium (ARPE19) cells.

Szurman P, Kaczmarek R, Spitzer MS, Jaissle GB, Decker P, Grisanti S, Henke-Fahle S, Aisenbrey S, Bartz-Schmidt KU.

Exp Eye Res. 2006 Sep;83(3):584-92. Epub 2006 May 8.

PMID:
16684520
41.

Instrumentation and technique for delivery of tissue explants to the subretinal space.

Thumann G, Aisenbrey S, Schaefer F, Bartz-Schmidt KU.

Ophthalmologica. 2006;220(3):170-3.

PMID:
16679791
42.

Sutureless amniotic membrane fixation using fibrin glue for ocular surface reconstruction in a rabbit model.

Szurman P, Warga M, Grisanti S, Roters S, Rohrbach JM, Aisenbrey S, Kaczmarek RT, Bartz-Schmidt KU.

Cornea. 2006 May;25(4):460-6.

PMID:
16670486
43.

Iris pigment epithelial translocation in the treatment of exudative macular degeneration: a 3-year follow-up.

Aisenbrey S, Lafaut BA, Szurman P, Hilgers RD, Esser P, Walter P, Bartz-Schmidt KU, Thumann G.

Arch Ophthalmol. 2006 Feb;124(2):183-8.

PMID:
16476887
44.

[Macular translocation after photodynamic therapy: a case report].

Gelisken F, Aisenbrey S, Bartz-Schmidt U.

Klin Monbl Augenheilkd. 2005 Sep;222(9):747-8. German. No abstract available.

PMID:
16231867
45.

[Multiple tumors of the eyelid].

Süsskind D, Aisenbrey S, Rohrbach JM.

Ophthalmologe. 2006 May;103(5):421-3. German. No abstract available.

PMID:
16078063
46.

Experimental implantation and long-term testing of an intraocular vision aid in rabbits.

Szurman P, Warga M, Roters S, Grisanti S, Heimann U, Aisenbrey S, Rohrbach JM, Sellhaus B, Ziemssen F, Bartz-Schmidt KU.

Arch Ophthalmol. 2005 Jul;123(7):964-9.

PMID:
16009839
47.

Histopathological analysis in experimental macular surgery with trypan blue.

Grisanti S, Szurman P, Tatar O, Gelisken F, Aisenbrey S, Oficjalska-Mlynczak J, Kaczmarek R, Bartz-Schmidt KU.

Br J Ophthalmol. 2004 Sep;88(9):1206-8.

48.

Immunohistopathologic evaluation of choroidal neovascular membranes following verteporfin-photodynamic therapy.

Grisanti S, Tatar O, Canbek S, Lafaut BA, Gelisken F, Inhoffen W, Szurman P, Aisenbrey S, Oficjalska-Mlynczak J, Bartz-Schmidt KU.

Am J Ophthalmol. 2004 May;137(5):914-23.

PMID:
15126158
49.

Histological findings in experimental macular surgery with indocyanine green.

Grisanti S, Szurman P, Gelisken F, Aisenbrey S, Oficjalska-Mlynczak J, Bartz-Schmidt KU.

Invest Ophthalmol Vis Sci. 2004 Jan;45(1):282-6.

PMID:
14691185
50.

Vogt-Koyanagi-Harada syndrome associated with cutaneous malignant melanoma: an 11-year follow-up.

Aisenbrey S, Lüke C, Ayertey HD, Grisanti S, Perniok A, Brunner R.

Graefes Arch Clin Exp Ophthalmol. 2003 Dec;241(12):996-9. Epub 2003 Nov 14.

PMID:
14618342

Supplemental Content

Loading ...
Support Center